https://orcid.org/0000-0002-2953-2188
Figures
Abstract
Background
To describe Purtscher’s and Purtscher-like retinopathy clinical features, etiologies, management options, and visual outcomes.
Methods
Our protocol was registered on PROSPERO [registration number: CRD42023406843]. Seven online databases were searched: PubMed, Scopus, Medline, ScienceDirect, CENTRAL, clinicaltrials.gov, and Google Scholar. Original articles were included if they reported at least one subject diagnosed with Purtscher’s or Purtscher-like retinopathy. The primary outcome is to describe the clinical features of Purtscher and Purtscher-like retinopathies, including etiologies, results of related investigations, management lines, and visual outcomes. All analyses were conducted with the use of Statistical Package for Social Sciences (SPSS) version 27 (IBM SPSS Corp, SPSS Statistics ver. 26, USA) and Cochrane’s RevMan software. The methodological quality of included studies was assessed using the NIH quality assessment tools.
Results
A total of 114 articles were included, describing 168 cases of Purtscher’s and Purtscher-like retinopathy. Patients were evenly distributed between males (50.89%) and females (49.11%). Average age of patients was 34.62 years old. Trauma was the leading cause of retinopathy, being reported in 39.88% of our patients, followed by systemic lupus erythematosus (SLE) (13.1%) and acute pancreatitis (11.9%). Bilateral symptoms were reported in 57.7% of patients with centrally blurred vision being the most complained symptom (OS: 34.32% and OD: 18%). 75% of patients elicited bilateral retinal findings. Cotton-wool spots were of highest prevalence (58%). Purtscher flecken was seen in 53% of patients. Macular edema was seen in 13% of patients. Overall, patients had a favorable prognosis (53%).
Conclusion
Purtscher’s and Purtscher-like retinopathies are rare sight-threatening retinopathies that develop most commonly following trauma or other systemic diseases as SLE and acute pancreatitis. Little data is available regarding these conditions, and available data is of low quality. Patients develop bilateral disease in approximately 50% of cases, and several retinal findings are observed, with no specific tendency. Most observed signs are cotton-wool spots in around 55% of patients and Purtscher flecken in 51% of patients. Patients spontaneously recovered, although data is not conclusive. No clear prognostic value of etiological factors is identified, and further research is required in this regard.
Citation: Serhan HA, Abuawwad MT, Taha MJJ, Hassan AK, Abu-Ismail L, Delsoz M, et al. (2024) Purtscher’s and Purtscher-like retinopathy etiology, features, management, and outcomes: A summative systematic review of 168 cases. PLoS ONE 19(9): e0306473. https://doi.org/10.1371/journal.pone.0306473
Editor: Kai Januschowski, Mount Saint Peter Eye Clinic, University of Tuebingen, GERMANY
Received: March 1, 2024; Accepted: June 18, 2024; Published: September 6, 2024
Copyright: © 2024 Serhan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Background
First described in 1910 by Otmar Purtscher, Purtscher’s retinopathy is a form of traumatic retinal angiopathy. It is brought about by occlusive microvasculopathy which may be associated with intraretinal hemorrhages, and often presents with sudden regression of visual acuity, bilaterally, within two days of trauma. A few potential pathological mechanisms resulting in Purtscher’s retinopathy were described in literature, all of which suggest that the most likely cause of the flecken is a precapillary arteriolar occlusion due to an embolus. Some these mechanisms include raised intracranial pressure and extravasation of lymph, raised intrathoracic pressure and venous dilatation, and vasculitis due to free fatty acids [1]. Retinas affected by Purtscher’s retinopathy often elicit Purtscher flecken (areas of retinal whitening), retinal hemorrhages, and cotton-wool spots [2–4]. Purtscher-like retinopathy is a similar retinopathy that is not related to traumatic origin but rather develops in the setting of pancreatitis, kidney disease, malignancy, hemolytic uremic syndrome (HUS), autoimmune diseases (e.g. Systemic lupus erythematosus (SLE)), and several other systemic and infectious illnesses including the novel COVID-19 [5]. The incidence of Purtscher-like retinopathy has been linked to multiorgan failure or advanced disease, leading to fatality [6].
Diagnosis of Purtscher-like retinopathy is often done clinically. A history of etiological factors in association with clinical signs can be sufficient to diagnose patients. Purtscher flecken seen on fundoscopy are considered pathognomic, although not seen in 50% of patients, however; other findings like cotton-wool spots and intraretinal hemorrhages can also aid in diagnosis [2, 5, 7]. The main hypothesis for the pathophysiology of Purtscher-like retinopathy is an occlusion of peripapillary terminal arterioles. This occlusion occurs due to a sequence of inflammation, leukoembolization, endothelial damage, activation of complement C5, and C5a predisposition of leukocytes (granulocytes) aggregation [1, 8]. Around 60% of cases of this condition are bilateral [6]. The incidence of Purtscher’s retinopathy is not clear, as some reports have estimated the annual incidence of Purtscher’s and Purtscher-like retinopathies to be approximately 0.24 individuals per million, while others assumed the incidence to be higher since this condition could often be asymptomatic [5].
Overall, cases of Purtscher’s and Purtscher-like retinopathy are managed conservatively, with marked visual improvement spontaneously occurring. Nevertheless, some literature suggests that patients benefit from intravenous methylprednisolone pulse, suggesting it helps restore microvasculature and inhibit granulocyte aggregation. Otherwise, symptomatic treatment has been used, such as anti-vascular endothelial growth factor for cases with macular edema, steroids, and immunosuppressive therapy for autoimmune disease-related cases [9–12]. In this systematic review of the literature, we attempt to explore clinical features, causes, cross-correlations, management and prognostic factors in Purtscher’s and Purtscher-like retinopathy.
Methods
This systematic review was conducted as per the recommendation of the PRISMA checklist for systematic reviews and meta-analyses (S1 Checklist). Our protocol was registered on PROSPERO prospectively [registration number: CRD42023406843]. This study adhered to the tenets of the Declaration of Helsinki. Given that our study did not involve human subjects, an institutional review board (IRB) approval was not required. On June 14, 2023, seven online databases were searched: PubMed, Scopus, Medline, ScienceDirect, Cochrane Central Register of Controlled Trials (CENTRAL), clinicaltrials.gov, and Google Scholar.
The search query was built following the PICO framework: participants were patients diagnosed with Purtscher’s or Purtscher-like retinopathy, and no restrictions applied on the interventions, comparators, and describing clinical features, etiologies, management options, and visual outcomes. In addition, no restrictions were applied depending on language, publication date, or study design. The primary outcome is to describe the clinical features of Purtscher and Purtscher-like retinopathies, including etiologies, results of related investigations, management lines, and visual outcomes. Secondary outcome included provide prognostic factors for Purtscher or Purtscher-like retinopathies related to the underlying etiology.
The search including the following keywords ((Purtscher[tiab] OR Purtscher-like[tiab] OR Pseudo-Purtscher) AND retinopath*[tiab]. The search criteria were modified as per the searched database. In addition, an updated manual search was performed to avoid missing any potentially related studies.
Eligibility criteria
Original research articles were included if they reported at least one subject diagnosed with Purtscher’s or Purtscher-like retinopathy. In the meantime, studies were excluded if they met at least one of the following criteria: (1) articles not reporting the target population, (2) non-original research (i.e., reviews, commentaries, guidelines, editorials, correspondence, and letters to editors), (3) unavailable full texts, (4) abstract-only papers with no published full texts, (5) duplicated studies, and (6) studies with unextractable data.
Selection of studies
Retrieved articles from electronic databases were imported in Endnote Software for duplicate removal. Then, citations were exported an Excel Sheet for screening. Screening was performed on two steps: title/abstract and full text screening. Two sets of two reviewers each [LAI and MD; HAA and OM] carried out the screening process, where the titles, abstracts, and full texts of all records were screened simultaneously by two reviewers. Differences between reviewers were solved by a thorough discussion, and when necessary, the senior authors [HAS and AGE] were consulted to give a final decision in unsolved disputes.
Data extraction
Two reviewers [HAS and AGE] developed the data extraction sheet with the use of Microsoft Excel. The extraction sheet included three parts: baseline characteristics, main outcomes, and secondary outcomes. The first part included references’ information (i.e., author name, year of publication, study design, and sample size [number of patients and eyes]) and patients’ characteristics (i.e., intervention and comparison groups, type of retinopathy, age, and gender). The second part included data related to Purtscher’s or Purtscher-like retinopathy, such as the etiology, symptoms, signs, and management lines. The third part was related to the quality assessment and risk of bias of the include articles. Two sets of two reviewers each [LAI and MD; HAA and OM] extracted relevant data from finally included articles. Finally, two senior authors checked the accuracy of extracted data before the analysis [HAS and AGE].
Risk of bias assessment
The methodological quality of included studies was assessed using the National Institute of Health (NIH) quality assessment tools (https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools) for each respective study design included. The NIH tool assesses the included of studies at the level of several domains: research question, study population, sample size justification, inclusion and exclusion criteria prespecified and applied uniformly, case and control definitions, random selection of study participants, exposure assessed prior to outcome measurement, exposure measures and assessment, blinding of exposure assessors and statistical analysis. Each of these domains is given a final decision of no information or good (>7), fair (4–7), or poor (<4). Finally, each study is given a final evaluation based on the evaluation reported in all domains. The quality assessment was performed by two sets of two reviewers, where each article was assessed by [LAI and MD; HAA and OM]. Any differences between reviewers were solved by discussion, and the senior authors [HAS and AGE] were consulted to give a final decision regarding any unsolved disputes.
Data synthesis and analysis
All analyses were conducted per-protocol (CRD42023406843) according to assessed patients with the use of Statistical Package for Social Sciences (SPSS) version 27 (IBM SPSS Corp, SPSS Statistics ver. 26, USA) and Cochrane’s RevMan software. We performed descriptive analysis presenting the categorical variables as percentages and frequencies while numerical variables as a mean and standard. The significance of the data was assessed using a categorical Chi-square test. All statistical tests were conducted with a 95% confidence interval and a 5% error margin. A p-value of less than 0.05 was considered statistically significant.
Results
Characteristics of the included studies
Our initial search concluded 1084 articles. Filtration was done according to the inclusion criteria, yielding 114 papers after the final stage. Fig 1 describes the filtration process according to the PRISMA guidelines. Included articles described 168 cases of Purtscher’s or Purtscher-like retinopathy with ages ranging from 2–75 years, with an average of 34.62 years. Of patients, 49.11% were female, and cases were reported from countries all over the world. Table 1 includes a summery for all included articles.
Causes of Purtscher’s & Purtscher-like retinopathy
The causative co-morbidity of retinopathy for each patient in our review was recorded. About 80.37% had clear causative co-morbidity, with trauma being the leading cause. Head/face trauma and other site trauma were the leading causes of retinopathy in 22.62% and 17.26% of included subjects respectively. Other causes had little prevalence, except for SLE (13.1%) and acute pancreatitis (11.9%), which had a relatively higher occurrence. Table 2 summarizes the prevalence of each causative co-morbidity in our review.
Diagnostic tests used for investigation
Patients were diagnosed by several methods, and reported diagnostic tests were aggregated in Table 3. Most patients were subjected to multiple diagnostic tests to assess different parts of the eye. In general, four tests were mostly acquired, namely fluorescence angiography (61.9%), fundus photography (55.95%), slit lamp (55.36%), and optical coherence tomography (OCT) (41.07%).
Relationship between cause of retinopathy and visual prognosis
The relationship between causes of retinopathy and the prognosis for affected eyes has been assessed using Chi-square analysis. Prognosis for each eye was either explicitly stated or acquired from final best corrected visual acuity (BCVA) changes during the follow-up period. We defined good prognosis as any improvement in the final BCVA, while poor prognosis as worsening of final BCVA compared to presentation. Unfortunately, no significant correlation was observed between cause of retinopathy and the extent of effect. Table 4 shows the relationship as described in cases.
In patients, BCVA before and after treatment was used as an indicator for visual improvement/regression. Overall, patient showed great variety in terms of presentation BCVA, both OD and OS, however; after treatment, the trend was towards 0 logMAR BCVA, which corresponds to normal vision.
Eye symptoms reported by patients
Tables 5–8 summarize our findings regarding presenting symptoms, signs and finding in the retinas of patients. Regarding symptoms, they were centered around loss of vision, weather central or peripheral, blurring or sudden, without reports of pain. Of patients, 97 (57.7%) reported bilateral symptoms. The most reported symptom was OS centrally blurred vision at 34.32%, while OD central vision blurring was reported in approximately 18% of patients. Other symptoms were reported especially OD, including floaters, scotomas, ptosis, and color vision affection (Table 5).
Eye signs reported in patients
Table 6 summarizes signs observed in patients. Bilaterality was noted in about 75% of patients, which is significantly higher than reported symptoms. Cotton-wool spots were of highest prevalence, as they were reported OD in 56.8% of patients and OS in 58% of patients. Following, retinal whitening was seen in approximately 53% patients OD and 50% patients OS, then retinal hemorrhages was reported in around 50% of patients OD and OS. Several other signs were observed to a lesser extent.
Correlation between observed signs and visual prognosis
In order to assess findings of prognostic visual value, Chi-square analysis was conducted. Interestingly Purtscher flecken (p<0.01), Cotton-wool spots (p<0.01), and optic nerve swelling (p<0.01) were associated with unknown or good visual prognosis (Table 7). No specific clinical finding was found to be associated with poor visual prognosis. However, data were insufficient to provide clear prognostic value of observed signs due to high missing data from the primary included studies.
Types of retinal complications
Retinal complications were also recorded in patients. Most notably, macular edema was seen in 13% of patients. It is important to note that a wide range of retinal complications has been observed in patients. Table 8 contains a summary for the prevalence of complications among patients.
Treatment options utilized
Patients were managed according to their condition. In our review, treatments fell into six major categories, the most used of which was conservative management (60.7%). Systemic and topical corticosteroids in different doses were administered to 16.1% of included subjects. Combined anti-VEGF and laser therapy injections were used in 7.1%, and remaining modalities were acquired in small groups making 5% or less of patients (Table 9).
Discussion
Purtscher’s and Purtscher-like retinopathy are sight threatening retinal conditions that manifest in relation to trauma or co-morbidity, respectively [2]. In this review, we attempt at a cross-comparison between published cases, in order to explore common factors in incidence, clinical picture, and prognosis. It is important to note that relatively low number cases are available in literature, as per our search, only 114 cases are available across all major medical research databases. Also, many published cases are of low quality. However, this review is the largest review discussing this rare entity.
The average age of included subjects is 34.62 years, which is consistent with similar cohorts in literature [5, 125]. However, our age group had a wide range, including patients as young as 2 years old, and as old as 75. Subjects were almost evenly distributed between males (50.89%) and females (49.11%). In this regard, literature suggests that males are subjected to head trauma or traumatic brain injuries at higher rates than females, reaching 40% more likelihood [126, 127]. On the contrary, acute pancreatitis, being the most reported co-morbidity with Purtscher-like retinopathy, is equally distributed between both sexes [128]. Of note, is the fact that epidemiological data for Purtscher’s and Purtshcer-like retinopathies is not sufficiently aggregated nor classified, making the identification of specific age/sex group as a risk group difficult.
In our review, only 80.37% of cases had clear related co-morbidity reported, which could hinder the full understanding of related causality. Nevertheless, of reported reasons, 67 (39.88%) patients reported a history of recent trauma, the majority of whom had head or facial trauma. This is reasonable, since the definition of Purtscher’s retinopathy includes the traumatic causality [2, 5]. As to Purtscher-like retinopathy, the most reported co-morbidity was SLE (13.1%) followed by acute pancreatitis (11.9%). Only one systematic review is available to compare these results, namely Miguel et al., and the findings in our study do not concede, as it reports acute pancreatitis to be the most reported co-morbidity [5]. However, our review has a much larger sample size, which gives more confidence in our findings. Both SLE and acute pancreatitis are associated with altered hemostasis, pre-disposing patients to retinal microangiopathy [46, 125]. But each of these diseases affects a different age group, as SLE is often manifested in younger individuals, i.e. second to third decade of life, while pancreatitis develops in older adults within their fifth to sixth decades [129, 130]. Thus, the connection between SLE and Purtscher’s retinopathy agrees with the findings regarding average age of patients affected. We conducted a chi-square analysis to assess the link between the predisposing co-morbidity and prognosis, with insignificant results due to poor available information. It was suggested in Miguel et al. study that male gender and etiological factors (acute pancreatitis and trauma) are of important prognostic value, but these findings are lacking in statistical power, in addition to being biased since most cases in the study are trauma or acute pancreatitis in the first place [5].
Information about the clinical picture in Purtscher’s and Purtscher-like retinopathies has been also recorded. Bilateral symptoms were reported in 97 (57.7%) patients, but upon examination, 75% of patients had bilateral findings. In the Miguel et al. study, bilaterality was reported in 14/68 (20.95%) cases [5]. Another study investigating Purtscher-like retinopathy in SLE patients reported bilaterality in 15/17 (88.2%) patients, however; this could be related to the nature of SLE, being a systemic multi-system disease [125].
Symptoms and signs did not have any tendency towards right or left eye and were evenly distributed. Patients complained mostly of centrally blurring of vision (OS: 34.32%, OD: 18%), however; these percentages suggest a high heterogenicity in symptoms presented.
Regarding signs, patients mostly had cotton-wool spots and retinal whitening. Retinal whitenings, known as Purtscher flecken are important features of Purtscher’s as the name implies [2]. Some literature considered that the presence of Purtscher flecken and cotton-wool spots along with etiological factors as a suitable diagnostic criterion for Purtscher’s and Purtscher-like retinopathies, which is questionable since Purtscher flecken were present in 50–53% of our patients only, and in 63.23% of patients in the Miguel et al. study [5, 125]. These findings manifest due to retinal artery occlusion by emboli of various origins and natures [2]. Retinal whitening manifests due to occlusion to the proximal retinal artery, while cotton-wool spots develop due to distal artery occlusion with small emboli [1]. Since distal arteries are of smaller diameter, smaller emboli are needed to exert effect, thus; cotton-wool spots are more likely to develop, which is what our data suggests. Retinal complications were specifically assessed, and were very diverse, making the most common complication macular edema which was seen in 13% of patients.
Overall, patients had a favorable prognosis (53%), which was also reported in an article by Schmidt and Otto on prognosis in Purtscher’s patients [131]. Although some complications are expected at a higher frequency as a result of the etiology of Purtshcer’s retinopathy, namely, trauma; No specific clinical finding was found to be associated with poor visual prognosis. Trauma-related complications as retinal detachment or vitreous hemorrhage were reported in a minority of patients (2.96% and 4.73%, respectively). This diversity of retinal complications can be attributed to the broad etiological base by which retinopathy develops, and our findings suggest the certain findings might have a significant prognostic value. Although about a third of reviewed articles did not provide clear prognostic description, we found that Purtscher flecken, cotton-wool spots, and optic nerve swelling might correlate to better improvement and favorable prognosis (p<0.01). However, the findings Schmidt and Otto suggest otherwise, as their work finds Purtscher flecken to correspond with worse prognosis. In addition, depending on case reports and series to provide strong evidence of the prognostic value couldn’t be conclusive.
Treatment of Purtshcer’s and Purtscher-like retinopathy are rather limited, especially with its ambiguous pathology. Generally speaking, each case should be individually assessed and managed, nevertheless; certain clinical features could help guide physicians. Since most patients were managed conservatively (60.7%), the primary clinical presentation is often indicative of no further complication, hence; no further intervention would be needed. In cases where complications develop, each complication calls for a suitable treatment modality. In our cohort, according to presentation and complications, modalities as corticosteroid-based management (16.1%), and combined anti-VEGF & laser therapy (7.1%) were used. A systematic review conducted by Xia et al. investigated the efficacy of Purtscher’s treatments on 139 eyes of 88 patients. In their study, glucocorticoids were used the most, in 63.29% of eyes, and conservative observation was used in 43.17% [132]. This suggests that management of Purtscher’s retinopathy patients can show great variety. In the Xia et al. study, patients showed improved vision across all groups, and no significant differences between treatment modalities was found. Moreover; similar to our observation, the quality of available evidence in this regard is rather poor, and no conclusive statements can be made [132]. A direct link between etiology-complication-treatment cannot be drawn from available information, moreover; treatment of Purtscher’s and Purtscher-like retinopathies often tend to the underlying systemic disease (e.g. SLE or Pancreatitis), making a specific management criterion tailored to Purtshcer’s or Purtscher-like retinopathy difficult to develop. Future research in this regard could assist in developing treatment guidelines for Purtscher’s and Purtscher-like retinopathies.
Limitations to this study can be summarized in the scarcity of available data, as well as the low quality of most cases reported. Future research in this topic should consider this limitation, as by overcoming them, a robust diagnostic criterion for Purtscher’s and Purtscher-like retinopathies can be developed. In addition, the nature of case reports and series may introduce bias and limit the generalizability of our findings raising questionable associations and prognostic values. Moreover, future research should pay attention to establishing a conventional treatment modality for these conditions, and to recognizing prognostic factors in order to prevent visual deterioration and loss.
Conclusion
Purtscher’s and Purtscher-like retinopathies are rare sight-threatening retinopathies that develop most commonly following trauma or other systemic diseases as SLE and acute pancreatitis. Little data is available regarding these conditions, and available data is of low quality. Patients develop bilateral disease in approximately 50% of cases, and several retinal findings are observed, with no specific tendency. Most observed signs are cotton-wool spots in around 55% of patients and Purtscher flecken in 51% of patients. Patients spontaneously recovered, although data is not conclusive. No clear prognostic value of etiological factors is identified, and further research is required in this regard.
References
- 1. Agrawal A, McKibbin MA. Purtscher’s and Purtscher-like Retinopathies: A Review. Survey of Ophthalmology. 2006;51(2):129–36.
- 2.
Tripathy K, Patel BC. Purtscher Retinopathy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
- 3. Purtscher O. Noch unbekannte befunde nach schädeltrauma. Ber dtsch ophthalmol Ges. 1910;36:294–310.
- 4. Kalavar M, El Khatib B, Suelves AM, Yanoga F. Purtscher-like retinopathy in patients with COVID-19. Am J Ophthalmol Case Rep. 2023;32:101915. pmid:37663997
- 5. Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA. Systematic review of Purtscher’s and Purtscher-like retinopathies. Eye (Lond). 2013;27(1):1–13. pmid:23174749
- 6. Holló G. Frequency of Purtscher’s retinopathy. Br J Ophthalmol. 2008;92(8):1159. pmid:18653618
- 7. Agrawal A, McKibbin M. Purtscher’s retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol. 2007;91(11):1456–9. pmid:17556428
- 8. Buckley SA, James B. Purtscher’s retinopathy. Postgrad Med J. 1996;72(849):409–12. pmid:8935600
- 9. Yusuf IH, Watson SL. Purtscher retinopathies: are we aiming at the wrong target? Eye (Lond). 2013;27(6):783–5. pmid:23558212
- 10. Nesmith BL, Bitar MS, Schaal S. The anatomical and functional benefit of bevacizumab in the treatment of macular edema associated with Purtscher-like retinopathy. Eye (Lond). 2014;28(8):1038–40. pmid:24788018
- 11. Wang AG, Yen MY, Liu JH. Pathogenesis and neuroprotective treatment in Purtscher’s retinopathy. Jpn J Ophthalmol. 1998;42(4):318–22. pmid:9749875
- 12. Wu C, Dai R, Dong F, Wang Q. Purtscher-like retinopathy in systemic lupus erythematosus. Am J Ophthalmol. 2014;158(6):1335–41 e1. pmid:25205559
- 13. Abo-Zed A, Chrites M, Okane E, Arsalan Zaidi S. I Cannot See Your Face! A Case of Purtscher Disease. Chest. 2021;160(4).
- 14. Akiyama K, Iwasaki Y, Tanaka R. Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab. Case Rep Ophthalmol. 2021;12(2):531–7. pmid:34248587
- 15. Alaei R, Shen C, Chan BJ, Martin J. Purtscher-Like Retinopathy Secondary to Medication Induced Calcium-Alkali Syndrome and Acute Pancreatitis in a Pregnant Female. Ocul Immunol Inflamm. 2022;30(7–8):1564–7. pmid:33979245
- 16. Alahmadi RM, Hashim RT, Almogairin SM, Abu AM. Purtscher-like retinopathy as a first presentation of systematic lupus erythematosus. Ann Saudi Med. 2016;36(1):85–8. pmid:26922694
- 17. Alsberge JB, Chen JJ, McDonald HR. PURTSCHER-LIKE RETINOPATHY IN A PATIENT WITH MILK-ALKALI SYNDROME AND PANCREATITIS. Retin Cases Brief Rep. 2023;17(2):224–6. pmid:33973557
- 18. Alzahrani M, Rehman MA, Basodan T, Adnan I, Akhtar M. Purtscher’s retinopathy in scleroderma. GMS Ophthalmol Cases. 2019;9:Doc07. pmid:30984507
- 19. Arora N, Lambrou FH, Jr., Stewart MW, Vidrine-Parks L, Sandroni S. Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron. 1991;59(3):490–2. pmid:1758544
- 20. Ayaki M, Yokoyama N, Furukawa Y. Postpartum central retinal artery occlusion simulating Purtscher’s retinopathy. Ophthalmologica. 1995;209(1):37–9. pmid:7715926
- 21. Ayhan Z, Kaya SY, Ozcan MA, Saatci AO. Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection. GMS Ophthalmol Cases. 2017;7:Doc29. pmid:29326861
- 22. Baarsma GS, van Balen TM. Purtscher’s disease. Doc Ophthalmol. 1977;44(1):95–104. pmid:923421
- 23. Bader-Meunier B, Monnet D, Barnerias C, Halphen I, Lambot-Juhan K, Chalumeau M, et al. Thrombotic microangiopathy and Purtscher-like retinopathy as a rare presentation of juvenile dermatomyositis. Pediatrics. 2012;129(3):e821–4. pmid:22311994
- 24. Battista M, Cicinelli MV, Starace V, Lattanzio R, Bandello F. Purtscher-like features in new-onset diabetic retinopathy. Acta Diabetol. 2020;57(3):377–9. pmid:31402408
- 25. Bezzina AD, Bertuello I. A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient. Case Rep Ophthalmol Med. 2022;2022:7870179. pmid:36578921
- 26. Bhan K, Ashiq A, Aralikatti A, Menon KV, McKibbin M. The incidence of Purtscher retinopathy in acute pancreatitis. Br J Ophthalmol. 2008;92(1):151–3. pmid:18156386
- 27. Blodi BA, Johnson MW, Gass JD, Fine SL, Joffe LM. Purtscher’s-like retinopathy after childbirth. Ophthalmology. 1990;97(12):1654–9. pmid:2087295
- 28. Bui SK, O’Brien JM, Cunningham ET Jr. Purtscher retinopathy following drug-induced pancreatitis in an HIV-positive patient. Retina. 2001;21(5):542–5. pmid:11642392
- 29. Burton TC. Unilateral Purtscher’s retinopathy. Ophthalmology. 1980;87(11):1096–105. pmid:7243205
- 30. Ramos de Carvalho JE, Schlingemann RO, Oranje M, Bemelman FJ, van Schooneveld MJ. Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. Int Ophthalmol. 2018;38(1):399–407. pmid:28275964
- 31. Castillo P, Voigt K, Crockett C, Stout JT, Krance R, Naik S. Purtscher-like retinopathy: A rare presentation of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Pediatr Transplant. 2019;23(2):e13344. pmid:30661285
- 32. Castillo BV Jr, Khan AM, Gieser R, Shownkeen H. Purtscher-like retinopathy and Horner’s syndrome following coil embolization of an intracavernous carotid artery aneurysm. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):60–2. pmid:15133679
- 33. Cernea D, Dragoescu A, Novac M. HELLP Syndrome Complicated with Postpartum Subcapsular Ruptured Liver Hematoma and Purtscher-Like Retinopathy. Case Rep Obstet Gynecol. 2012;2012:856135. pmid:22852104
- 34. Chandra P, Azad R, Pal N, Sharma Y, Chhabra MS. Valsalva and Purtscher’s retinopathy with optic neuropathy in compressive thoracic injury. Eye (Lond). 2005;19(8):914–5. pmid:15359240
- 35. Chebil A, Mammouri R, Abdallah MB, El Matri L. Purtscher-like Retinopathy as a Rare Presentation of Cryoglobulinemia. Middle East Afr J Ophthalmol. 2016;23(2):219–21. pmid:27162457
- 36. Cheng CKL, Lai KKH, Kuk AKT, Lai THT, Wang ST, Ko STC. Purtscher-like retinopathy in a patient with lupus: a case report. Hong Kong Med J. 2022;28(1):79–81. pmid:35260497
- 37. Cheng S-y, Chen Y-x. Purtscher-Like Retinopathy Associated With Atypical Hemolytic Uremic Syndrome. JAMA Ophthalmology. 2023;141(7):e230589–e. pmid:37471062
- 38. Coban-Karatas M, Turunc T, Altan-Yaycioglu R. Purtscher-like retinopathy related to drug-induced hypersensitivity syndrome. Ocul Immunol Inflamm. 2012;20(6):475–7. pmid:23163426
- 39. Cumurcu T, Yardim H, Güven M, Kılıç R, Oezkan N. Purtscher’s retinopathy: An unusual association with a complicated mandibular fracture. Turkish Journal of Medical Sciences. 2008;38:373–6.
- 40. Devonport H, Oworu O, Mohla A, Kolli S, James T. Purtscher’s like retinopathy as the presenting feature of acute alcoholic pancreatitis. Eye. 2006;20(2):255–7. pmid:15803177
- 41. Durrani AK, Mehta VJ, Kim SJ. Postinfluenza Purtscher-like Retinopathy with Acute Macular Neuroretinopathy. Ophthalmol Retina. 2018;2(2):95. pmid:31047352
- 42. Dyrda A, Matheu Fabra A, Arones Santivanez JR, Blanch Rubio J, Alarcon Valero I. Purtscher-like retinopathy as an initial presentation of iron-deficiency anaemia. Can J Ophthalmol. 2015;50(1):e1–2. pmid:25677291
- 43. El Karoui K, Karras A, Lebrun G, Charles P, Arlet JB, Jacquot C, et al. Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still’s disease: a role for glomerular vascular endothelial growth factor? Arthritis Rheum. 2009;61(11):1609–13. pmid:19877102
- 44. Elwood KF, Dieu AC, Kuranz CV, Mititelu M. Purtscher-Like Retinopathy with Cardioembolic Stroke: Case Report and Literature Review. Case Rep Ophthalmol. 2022;13(3):943–8. pmid:36466061
- 45. Engelmann EWM, Tinley C, van As AB. Post-traumatic bilateral blindness in a toddler. Journal of Pediatric Surgery Case Reports. 2019;51.
- 46. Gahn GM, Khanani AM, Khan M, Aziz AA, Siddiqui FA, London NJ, et al. Purtscher’s-like retinopathy associated with acute pancreatitis. Am J Ophthalmol Case Rep. 2020;20:100892. pmid:32913924
- 47. Gange WS, Haghighi A, Toy BC. PURTSCHER-LIKE RETINOPATHY ASSOCIATED WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: CASE REPORT AND REVIEW OF OUTCOMES. Retin Cases Brief Rep. 2023;17(2):154–9. pmid:33492076
- 48. Şekeryapan Gediz B. Acute Macular Neuroretinopathy in Purtscher Retinopathy. Turk J Ophthalmol. 2020;50(2):123–6. pmid:32367705
- 49. Geraissate JC, Yamamoto RE, Isaac DL, Avila MP. Hemorrhagic retinopathy in an infant with hemolytic-uremic syndrome. Arq Bras Oftalmol. 2014;77(6):397–9. pmid:25627190
- 50. Giani A, Deiro AP, Sabella P, Eandi CM. SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AND FUNDUS AUTOFLUORESCENCE FINDINGS IN A CASE OF PURTSCHER-LIKE RETINOPATHY. Retinal Cases and Brief Reports. 2011;5(2).
- 51. Gibson SM, Cox A, Ross DJ. Purtscher’s retinopathy. Injury. 2000;31(6):472–4. pmid:10831751
- 52. Grabe HM, Zacks DN. A case of purtscher-like retinopathy following a motor vehicle accident. Retin Cases Brief Rep. 2009;3(4):369–71. pmid:25389850
- 53. Gungel H, Altan C, Karini B, Ozdemir FE, Celebi OO. CONTRALATERAL VISION LOSS AFTER ENDONASAL DACRYOCYSTORHINOSTOMY: A CASE REPORT OF PURTSCHER-LIKE RETINOPATHY AND TREATMENT WITH INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR. Retin Cases Brief Rep. 2019;13(3):255–9. pmid:28333851
- 54. Gupta OP, Zegere E, Maguire JI. Purtscher-like retinopathy associated with primary hypereosinophilic syndrome. Retin Cases Brief Rep. 2009;3(2):193–6. pmid:25391073
- 55. Haque WM, Ananna MA, Haque HF, Rahim MA, Samad T, Iqbal S. Purtscher’s retinopathy and renal cortical necrosis: two rare vaso-occlusive complications in a patient with acute pancreatitis: a case report. J Med Case Rep. 2016;10(1):326. pmid:27846860
- 56. Hashim SP, El Shafei M, Al, Ansari ZM. Purtscher’s retinopathy: A case of severe bilateral visual loss due to chest compression. Journal of Emergency Medicine, Trauma and Acute Care. 2012;2012(1).
- 57. Haslett RS, Duvall-Young J, McGalliard JN. Traumatic retinal angiopathy and seat belts: pathogenesis of whiplash injury. Eye (Lond). 1994;8 (Pt 6):615–7. pmid:7867815
- 58. Huang LC, Williams BK, Ko AC, Yehoshua Z, Alabiad CR. Purtscher-Like Retinopathy and Diffuse Alveolar Hemorrhage Caused by Soft Tissue Injection for Gluteal Augmentation. J Clin Exp Ophthalmol. 2015;6(1). pmid:33564495
- 59. Huang ZX, Zeng ZB, Xu ZP. [Purtscher-like retinopathy associated with antibiotic anaphylaxis]. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(3):239–42. pmid:29643027
- 60. Hupy ML, Pecen PE, Kolfenbach JR, Lau M, Palestine AG. PURTSCHER’S‒LIKE RETINOPATHY SECONDARY TO GRANULOMATOSIS WITH POLYANGIITIS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION. Retin Cases Brief Rep. 2022;16(4):444–7.
- 61. Hussain RM, Yung CW. Purtscher’s Retinopathy. Ophthalmology. 2016;123(8):1666. pmid:27450816
- 62. Inkeles DM, Walsh JB. Retinal fat emboli as sequela to acute pancreatitis. Am J Ophthalmol. 1975;80(5):935–8. pmid:1190285
- 63. İpek Ş C, Yaman A, Men S, Saatci AO. Unilateral Purtscher-like retinopathy as the presenting feature of a case with spontaneous carotid artery dissection. Clin Case Rep. 2021;9(5):e03633. pmid:34026118
- 64. Ishibashi T, Wakabayashi T, Nishida K. Purtscher-like Retinopathy Associated with Systemic Lupus Erythematosus Observed Using Wide-field OCT Angiography. Ophthalmol Retina. 2019;3(1):76. pmid:30929818
- 65. Ameen Ismail A, Tolba HE, Sadek SH, Hatata RM. Purtscher-like retinopathy following coronary artery bypass grafting in an antiphospholipid syndrome patient: a case report. BMC Ophthalmol. 2023;23(1):197. pmid:37142991
- 66. Jeon SY, Jung E, Seol HJ, Hur YJ. Development of Purtscher-like retinopathy after pre-eclampsia combined with acute pancreatitis. Obstet Gynecol Sci. 2013;56(4):261–4. pmid:24328012
- 67. Karasu B, Gunay BO, Erdogan G, Kardes E, Gunay M. Purtscher-Like Retinopathy Associated with Anorexia Nervosa. Case Rep Ophthalmol Med. 2016;2016:1934091. pmid:27069703
- 68. Kasi SK, Larson J, Stewart JM. Purtscher’s Retinopathy. Ophthalmology. 2017;124(7):1047. pmid:28645339
- 69. Kovach JL. GEMCITABINE-INDUCED RETINOPATHY. Retin Cases Brief Rep. 2018;12(3):240–1. pmid:27806002
- 70. Kozlowski JMD, Peters AL. Purtscher’s-like Retinopathy Associated With a Cardiac Aneurysm. Archives of Ophthalmology. 1992;110(6):880–1. pmid:1596238
- 71. Kunavisarut P, Pathanapitoon K, Rothova A. Purtscher-like Retinopathy Associated with Systemic Lupus Erythematosus. Ocul Immunol Inflamm. 2016;24(1):60–8. pmid:25019972
- 72. Kusano Y, Endo S, Mukai S, Yamaguchi T. Retinopathy after percutaneous transluminal coronary angioplasty and stent insertion for acute myocardial infarction. Am J Ophthalmol. 2003;136(3):557–60. pmid:12967820
- 73. Cho HK, Jee D, Lee WK, Shin CH, Ryu JW. Purtscher-like retinopathy after retrobulbar anaesthesia in a patient with an intracanal mass. Can J Ophthalmol. 2010;45(5):546–7. pmid:20648071
- 74. Lai WW, Chen AC, Sharma MC, Lam DS, Pulido JS. Purtscher-like retinopathy associated with acute renal allograft rejection. Retina. 2005;25(1):85–7. pmid:15655448
- 75. Lauer AK, Klein ML, Kovarik WD, Palmer EA. Hemolytic Uremic Syndrome Associated With Purtscher-like Retinopathy. Archives of Ophthalmology. 1998;116(8):1119–20. pmid:9715700
- 76. Lemagne JM, Michiels X, Van Causenbroeck S, Snyers B. Purtscher-like retinopathy after retrobulbar anesthesia. Ophthalmology. 1990;97(7):859–61. pmid:2381698
- 77. Li B, Li D, Chen Y. Purtscher-like retinopathy presented a honeycomb-like pattern in optical coherence topography angiography. BMC Ophthalmol. 2019;19(1):232. pmid:31752754
- 78. Li M, Jin Y, He J. Purtscher-like retinopathy associated with systemic lupus erythematosus treated with rituximab plus low-dose interleukin-2: A case report. Int J Rheum Dis. 2023;26(7):1373–6. pmid:36806905
- 79. Liang LL, Zhou DD, Lu CW. Purtscher-like Retinopathy. Am J Med Sci. 2017;354(3):330. pmid:28918844
- 80. Lima LH, Vianello S, Pimentel S, Costa de Andrade G, Zett C, Muller L, et al. Dengue Fever Presenting as Purtscher-like Retinopathy. Ocul Immunol Inflamm. 2018;26(5):660–5. pmid:28323496
- 81. Lin YC, Yang CM, Lin CL. Hyperbaric oxygen treatment in Purtscher’s retinopathy induced by chest injury. J Chin Med Assoc. 2006;69(9):444–8. pmid:17051757
- 82. Lipper J, Pazkowski J, Taub PJ. Purtscher’s Retinopathy as a Cause of Postoperative Blindness. Plastic and Reconstructive Surgery. 2008;122(2). pmid:18626320
- 83. Liu FC, Chiang SY, Chang DM, Lai JH, Hou TY, Chen CH. Purtscher’s-like retinopathy as an initial presentation of adult-onset Still’s disease: a case report and review of the literature. Clin Rheumatol. 2007;26(7):1204–6. pmid:16900301
- 84. Lujan BJ, Coady PA, McDonald HR. Spectral domain optical coherence tomography imaging of Purtscher-like retinopathy. Retin Cases Brief Rep. 2014;8(4):283–5. pmid:25372529
- 85. Madsen PH. Traumatic retinal angiopathy. Report of six cases of Purtscher’s disease. Acta Ophthalmol (Copenh). 1965;43(6):776–86. pmid:5898737
- 86. Mahmoud A, Zaghdoudi A, Boucharb S, Abid F, Mbarek S, Ibn Hadj Amor H, et al. Case Report: Purtscher-like retinopathy in a patient with lung adenocarcinoma. F1000Res. 2022;11:227. pmid:35388336
- 87. Mäntyjärvi M, Teräsvirta M, Hoffren M, Klemetti A. Color vision defect in Purtscher’s disease. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1993;231(10):609–11. pmid:8224939
- 88. Mariani AF, Major JC, Jr., Brown DM, Wykoff CC, Benz MS, Kegley EN. Purtscher-like retinopathy associated with pemphigus vulgaris. Retin Cases Brief Rep. 2013;7(4):304–6. pmid:25383823
- 89. Marr WG, Marr EG. Some Observations on Purtscher’s Disease: Traumatic Retinal Angiopathy* *From the Wilmer Ophthalmological Institute of The Johns Hopkins University and Hospital. American Journal of Ophthalmology. 1962;54(4):693–705.
- 90. Massa R, Vale C, Macedo M, Furtado MJ, Gomes M, Lume M, et al. Purtscher-like retinopathy. Case Rep Ophthalmol Med. 2015;2015:421329. pmid:25632360
- 91. Mbekeani JN, Raval NK, Vo TA, Rusu IM, Lin SZ, Coyle CM, et al. Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathy. Arq Bras Oftalmol. 2022;85(5):513–6. pmid:35946614
- 92. Meyer CH, Callizo J, Schmidt JC, Mennel S. Functional and anatomical findings in acute Purtscher’s retinopathy. Ophthalmologica. 2006;220(5):343–6. pmid:16954714
- 93. Narendran S, Saravanan VR, Pereira M. Purtscher-like retinopathy: A rare complication of peribulbar anesthesia. Indian J Ophthalmol. 2016;64(6):464–6. pmid:27488158
- 94. Nautiyal A, Amescua G, Jameson A, Gradowski JF, Hong F, Doft B. Sudden loss of vision: Purtscher retinopathy in multiple myeloma. CMAJ. 2009;181(12):E277. pmid:19901043
- 95. Nema N, Ishrat S, Verma A, Kela M. Purtscher-like retinopathy in acute alcoholic pancreatitis. Oman J Ophthalmol. 2016;9(2):110–2. pmid:27433040
- 96. Okwuosa TM, Lee EW, Starosta M, Chohan S, Volkov S, Flicker M, et al. Purtscher-like retinopathy in a patient with adult-onset Still’s disease and concurrent thrombotic thrombocytopenic purpura. Arthritis Rheum. 2007;57(1):182–5. pmid:17266110
- 97. Olson J, Rouhani B, Mandava N. Sub-Tenon’s triamcinolone for post-partum Purtscher’s-like retinopathy. Clin Ophthalmol. 2008;2(1):195–8. pmid:19668404
- 98. Orzalesi N, Coghe F. Obstructed axoplasmic transport in Purtscher’s traumatic retinopathy. Ophthalmologica. 1980;180(1):36–45. pmid:6160445
- 99. Park S, Lim L, Fetherston T. Purtscher’s Retinopathy Associated with Tortuous Internal Carotid Artery. Asian Journal of Ophthalmology. 2011;12:179–80.
- 100. Rahman EZ, Shah P, Ong JE, Goldberg M, Ong SS. Purtscher-like retinopathy in a patient with COVID-19 and disseminated intravascular coagulation. Am J Ophthalmol Case Rep. 2021;24:101229. pmid:34796309
- 101. Remky A, Arend O, Wolf S, Bertram B, Reim M. Morphologic changes of the macula in a patient with Purtscher’s retinopathy. Ophthalmologica. 1997;211(4):268–9. pmid:9216022
- 102. Saengsirinavin AO, Calman AF. Multimodal Imaging of Purtscher-like Retinopathy. Ophthalmol Retina. 2017;1(3):255. pmid:31047431
- 103. Sauer A, Nasica X, Zorn F, Petitjean P, Bader P, Speeg-Schatz C, et al. Cryoglobulinemia revealed by a Purtscher-like retinopathy. Clin Ophthalmol. 2007;1(4):555–7. pmid:19668536
- 104. Shah RJ, Choudhry N, Leiderman YI. Purtscher-like retinopathy in association with metastatic pancreatic adenocarcinoma and capecitabine therapy. Retin Cases Brief Rep. 2013;7(3):196–7. pmid:25391104
- 105. Shah VM, Gawas G. Purtscher’s retinopathy in one and sixth nerve palsy in the other eye following head trauma. GMS Ophthalmol Cases. 2019;9:Doc09. pmid:30984509
- 106. Sharma A, Reddy Y, Shetty AP, Kader SMA. Electric shock induced Purtscher-like retinopathy. Indian J Ophthalmol. 2019;67(9):1497–500. pmid:31436214
- 107. Shroff D, Kumar S, Naidu A, Gupta C. Unilateral Purtscher-like retinopathy post-COVID-19. Indian J Ophthalmol. 2022;70(10):3710–2. pmid:36190079
- 108. Shukla D, Maheshwari R, Ramchandani B, Kanungo S. Purtscher-like retinopathy with serous retinal detachment in preeclampsia of pregnancy: complications and management. Retin Cases Brief Rep. 2010;4(4):332–5. pmid:25390911
- 109. Stassen LF, Goel R, Moos KF. Purtscher’s retinopathy: an unusual association with a complicated malar fracture. Br J Oral Maxillofac Surg. 1989;27(4):296–300. pmid:2669944
- 110. Stoumbos VD, Klein ML, Goodman S. Purtscher’s-like retinopathy in chronic renal failure. Ophthalmology. 1992;99(12):1833–9. pmid:1480400
- 111. Subudhi P, Kanungo S, Rao Subudhi N. Purtscher’s-like retinopathy in acute alcoholic pancreatitis. BMJ Case Rep. 2016;2016. pmid:27628016
- 112. Tabatabaee S-A, Soleimani M, Mansouri M-R, Jabarvand M, Nili-AhmadAbadi M, Mirshahi A, et al. Purtscher Retinopathy Associated with Valsalva Retinopathy after Accident. Iranian Journal of Ophthalmology. 2009;21.
- 113. Tang AA, Lin AL. Purtscher-like retinopathy in adult-onset Still’s disease, complicated by treatment-related central serous chorioretinopathy. Am J Ophthalmol Case Rep. 2020;18:100631. pmid:32140617
- 114. Tariq T, Reaume M, Hammar D, Shallal A, Schauer M. Blind After a Binge: Purtscher-like Retinopathy in Acute Alcoholic Pancreatitis. ACG Case Rep J. 2019;6(11):e00251. pmid:32309468
- 115. Tatlipinar S, Toprak İ, Yaylali V, Yildirim C, Keskin N, Özden S. Purtscher’s Retinopathy: A Case Report. Neuro-Ophthalmology. 2009;31(3):83–5.
- 116. Thatcher MD, Wu LZ, Varma R. Bilateral Purtscher-Like Retinopathy Associated With COVID-19 Infection. JAMA Ophthalmol. 2023;141(3):291–3. pmid:36757710
- 117. Vezzola D, Allegrini D, Romano MR, Pagano L, Montericcio A, Fogagnolo P, et al. Optical coherence tomography angiography in Purtscher-like retinopathy associated with dermatomyositis: a case report. J Med Case Rep. 2019;13(1):206. pmid:31277711
- 118. Viola F, Vezzola D, Villani E, Mapelli C, Barteselli G, Ratiglia R. Purtscher-like Retinopathy in Septicemic Disseminated Intravascular Coagulation Associated with Nephrotic Syndrome. Eur J Ophthalmol. 2013;23(4):601–3. pmid:23640504
- 119. Yalinbas D, Bozali E, Vural A, Kocak H, Erdogan H. Purtscher-like Retinopathy Associated with Crimean-Congo Hemorrhagic Fever: A Case Report. Ocul Immunol Inflamm. 2022;30(4):1016–9. pmid:33428499
- 120. Yan Y, Shen X. Purtscher-like retinopathy associated with dermatomyositis. BMC Ophthalmol. 2013;13:36. pmid:23883070
- 121. Yang HS, Joe SG, Yoon YH, Kim JG. A case of Purtscher retinopathy associated with stent-assisted coil embolization of a middle cerebral artery aneurysm. Eur J Ophthalmol. 2013;23(2):262–6.
- 122. Yao A, Wang B. Blindness and acute pancreatitis: Purtscher-like retinopathy. Med J Aust. 2019;210(8):351–e1. pmid:30977145
- 123. Zaidi M, Mishra K, Nguyen HV, Miller PP, Ghoraba H, Karaca I, et al. C3 glomerulopathy associated with both hypertensive retinopathy and purtscher-like retinopathy. Am J Ophthalmol Case Rep. 2022;27:101683. pmid:36016724
- 124. Zwolińska D, Medyńska A, Galar A, Turno A. Purtscher-like retinopathy in nephrotic syndrome associated with mild chronic renal failure. Pediatr Nephrol. 2000;15(1–2):82–4. pmid:11095019
- 125. Meng L, Yu Q, Zhao X, Chen L, Wang Y, Zhang W, et al. Purtscher-like retinopathy in systemic lupus erythematosus: clinical features, risk factors and prognosis. QJM: An International Journal of Medicine. 2023;116(11):923–32. pmid:37665730
- 126. Gupte R, Brooks W, Vukas R, Pierce J, Harris J. Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know. J Neurotrauma. 2019;36(22):3063–91. pmid:30794028
- 127.
Faul M, Coronado V. Chapter 1—Epidemiology of traumatic brain injury. In: Grafman J, Salazar AM, editors. Handbook of Clinical Neurology. 127: Elsevier; 2015. p. 3–13.
- 128. Drake M, Dodwad SJ, Davis J, Kao LS, Cao Y, Ko TC. Sex-Related Differences of Acute and Chronic Pancreatitis in Adults. J Clin Med. 2021;10(2). pmid:33467580
- 129.
Gapp J, Tariq A, Chandra S. Acute Pancreatitis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
- 130. Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. 2022;14(10):e30330. pmid:36407159
- 131. Schmidt D, Otto T. Prognose und Differenzialdiagnose des Morbus Purtscher. Der Ophthalmologe. 2004;101(6):576–83. pmid:15197574
- 132. Xia D, Chen X, Zhou Q, Xiao S, Yu Y, Wang Y, et al. Efficacy of Purtscher’s Retinopathy Treatments: A Systematic Review. Current Eye Research. 2017;42(6):908–17. pmid:28139150